Fight Colorectal Cancer and MiraLAX® Partner to Provide Bathroom on the National Mall for Colorectal Cancer Awareness
March 15, 2023 11:28 ET
|
Fight Colorectal Cancer
Springfield, Mo., March 15, 2023 (GLOBE NEWSWIRE) -- National nonprofit Fight Colorectal Cancer (Fight CRC) and over-the-counter laxative, MiraLAX® are partnering this March, Colorectal Cancer...
Mainz Biomed Announces Partnership with Labor Staber to Expand ColoAlert Commercialization in Germany
March 15, 2023 03:01 ET
|
Mainz BioMed NV
BERKELEY, Calif. and MAINZ, Germany, March 15, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the...
Mainz Biomed Launches Number of Educational Events in Germany to Raise Awareness for CRC Screening and Early Detection
March 08, 2023 03:01 ET
|
Mainz BioMed NV
Sponsor of Gastro Update 2023, 2-day scientific and training events for gastroenterology professionals Patient Education Day in the City of Mainz, Germany, where the Company is headquartered ...
Immuneering Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
March 06, 2023 16:05 ET
|
Immuneering Corporation
First patient dosed in Phase 1/2a clinical trial of IMM-1-104 in advanced solid tumors with any RAS mutation Provides debut guidance for IMM-1-104 program: initial Phase 1 PK and safety data expected...
Landmarks across the country go Blue for Colorectal Cancer Awareness Month
March 03, 2023 02:56 ET
|
Colon Cancer Coalition
Minneapolis, March 03, 2023 (GLOBE NEWSWIRE) -- In recognition of Colorectal Cancer Awareness Month, civic, public, and private buildings and landmarks across the United States are slated to go BLUE...
United in the Fight Against Colorectal Cancer
March 01, 2023 17:42 ET
|
Fight Colorectal Cancer
Springfield, Mo., March 01, 2023 (GLOBE NEWSWIRE) -- On the heels of the White House declaring March as Colorectal Cancer Awareness Month, urging the public to get screened, national advocacy...
Mainz Biomed Recognizes Colorectal Cancer Awareness Month Throughout “Blue” March 2023
March 01, 2023 03:01 ET
|
Mainz BioMed NV
BERKELEY, Calif. and MAINZ, Germany, March 01, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the...
For Colorectal Cancer Awareness Month, the Colon Cancer Coalition invites the country to Talk Sh!t to save lives
February 28, 2023 18:58 ET
|
Colon Cancer Coalition
Created in conjunction with BeautifulBeast, an independent cross-cultural agency, “Talking Sh!t Saves Lives” lives predominantly on Twitter, with the support of radio PSAs, digital videos, social...
Mainz Biomed to Appear on ClearThink IR’s Virtual Live Event on Wednesday, March 1, 2023 at 12 Noon ET
February 28, 2023 08:01 ET
|
Mainz BioMed NV
BERKELEY, Calif. and MAINZ, Germany, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, today announced that...
Mainz Biomed Acquires Entire Intellectual Property Portfolio for its Colorectal Cancer Diagnostic Test Program
February 21, 2023 03:01 ET
|
Mainz BioMed NV
Transaction entails executing option agreements to purchase IP portfolio associated with current ColoAlert product and the novel gene expression (mRNA) biomarkers being evaluated in ColoFuture/eAARLY...